Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer

Clinical trial NCT02228369 · COMPLETED

Trial details

NCT number: NCT02228369
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

EGFR Mutation Positive Advanced Non Small Cell Lung Cancer

Start date: 2014-11-05
Primary completion: 2017-08-19
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.